EQUILLIUM, INC. (EQ) ROI
- 2023-03-31: ROI -78.62%.
- 2022-12-31: ROI -152.65%.
- 2022-09-30: ROI -196.99%.
- 2022-06-30: ROI -143.34%.
Complete source-backed roi history.
- Available history
- 2020-09-30 to 2023-03-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2023-03-31 | -78.62% |
| 2022-12-31 | -152.65% |
| 2022-09-30 | -196.99% |
| 2022-06-30 | -143.34% |
| 2022-03-31 | -107.35% |
| 2021-12-31 | -50.93% |
| 2021-09-30 | -43.47% |
| 2021-06-30 | -35.50% |
| 2021-03-31 | -30.39% |
| 2020-12-31 | -37.36% |
| 2020-09-30 | -32.34% |
Annual ROI
| Date | ROI |
|---|---|
| 2022-12-31 | -152.65% |
| 2021-12-31 | -50.93% |
| 2020-12-31 | -37.36% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |